JAMP GATIFLOXACIN
JAMP GATIFLOXACIN
Approved
DIN Number
02533235
Drug Class
Human
Market Date
Dec 5, 2024
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02533235
AIG Number0142621005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01AE06 GATIFLOXACIN
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:04.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
GATIFLOXACINActive
Strength: 0.3 % / W/V
Monograph: GATIFLOXACIN